|
First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumors |
|
|
|
Titel: |
First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumors |
Auteur: |
Wei, Xiao-Li Wu, Hao-Xiang Ruan, Dan-Yun Wang, Feng Xu, Li Li, Yu-Hong Ma, Yu-Xiang Wang, Zhi-Qiang Yang, Yun-Peng Tang, Liang-Wei Chen, Bao-Lin Yong, Zhi-Quan Xu, Rui-Hua Zhao, Hong-Yun |
Verschenen in: |
Cell reports medicine |
Paginering: |
Jaargang 6 () nr. 2 pagina's p. |
Jaar: |
2025 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|